Adherence Inhibition of Cronobacter sakazakii to Intestinal Epithelial Cells by Lactoferrin
暂无分享,去创建一个
[1] B. Lönnerdal,et al. Longitudinal Changes in Lactoferrin Concentrations in Human Milk: A Global Systematic Review, , 2014, Critical reviews in food science and nutrition.
[2] J. Bean,et al. Cronobacter: an emerging opportunistic pathogen associated with neonatal meningitis, sepsis and necrotizing enterocolitis , 2013, Journal of Perinatology.
[3] R. Read,et al. Anti-adhesion methods as novel therapeutics for bacterial infections , 2012, Expert review of anti-infective therapy.
[4] H. Ford,et al. Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis. , 2012, The Journal of surgical research.
[5] B. Tall,et al. Cronobacter species (formerly known as Enterobacter sakazakii) in powdered infant formula: a review of our current understanding of the biology of this bacterium , 2012, Journal of applied microbiology.
[6] R. Hutkins,et al. Adherence Inhibition of Cronobacter sakazakii to Intestinal Epithelial Cells by Prebiotic Oligosaccharides , 2011, Current Microbiology.
[7] P. Whyte,et al. Cronobacter (Enterobacter sakazakii): an opportunistic foodborne pathogen. , 2010, Foodborne pathogens and disease.
[8] M. Garza,et al. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli , 2010, BioMetals.
[9] Li-Chun Lin,et al. Cronobacter sakazakii in foods and factors affecting its survival, growth, and inactivation. , 2009, International journal of food microbiology.
[10] J. Actor,et al. Lactoferrin as a natural immune modulator. , 2009, Current pharmaceutical design.
[11] A. Benson,et al. Diet-Induced Metabolic Improvements in a Hamster Model of Hypercholesterolemia Are Strongly Linked to Alterations of the Gut Microbiota , 2009, Applied and Environmental Microbiology.
[12] K. Yamauchi,et al. Inhibitory effects of bovine lactoferrin and lactoferricin B on Enterobacter sakazakii. , 2008, Biocontrol science.
[13] M. Loessner,et al. Enterobacter sakazakii Invasion in Human Intestinal Caco-2 Cells Requires the Host Cell Cytoskeleton and Is Enhanced by Disruption of Tight Junction , 2007, Infection and Immunity.
[14] T. Osaili,et al. Isolation of Enterobacter sakazakii and other Enterobacter sp. from food and food production environments , 2007 .
[15] L. G. Giugliano,et al. Human Milk Glycoproteins Inhibit the Adherence of Salmonella typhimurium to HeLa Cells , 2006, Microbiology and immunology.
[16] J. Gordon,et al. Identification of lipopolysaccharide-binding proteins in porcine milk. , 2006, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[17] G. Armstrong,et al. Prebiotic Galactooligosaccharides Reduce Adherence of Enteropathogenic Escherichia coli to Tissue Culture Cells , 2006, Infection and Immunity.
[18] C. Braden,et al. Invasive Enterobacter sakazakii Disease in Infants , 2006, Emerging infectious diseases.
[19] T. Ochoa,et al. Effect of lactoferrin on enteroaggregative E. coli (EAEC). , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[20] Nathan Sharon,et al. Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.
[21] Xiaoning Cai,et al. Real time PCR using TaqMan and SYBR Green for detection of Enterobacter sakazakii in infant formula. , 2006, Journal of microbiological methods.
[22] P. Valenti,et al. Lactoferrin , 2005, Cellular and Molecular Life Sciences.
[23] N. Orsi,et al. The antimicrobial activity of lactoferrin: Current status and perspectives , 2004, Biometals.
[24] R. W. Evans,et al. Lactoferrin--a multifunctional protein with antimicrobial properties. , 2003, Molecular immunology.
[25] C. Guzmán,et al. Lactoferrin Impairs Type III Secretory System Function in Enteropathogenic Escherichia coli , 2003, Infection and Immunity.
[26] M. Zimecki,et al. Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS‐induced inflammatory responses in mice , 2002, Clinical and experimental immunology.
[27] N. Sharon,et al. Fighting Infectious Diseases with Inhibitors of Microbial Adhesion to Host Tissues , 2002, Critical reviews in food science and nutrition.
[28] L. G. Giugliano,et al. Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells , 2001, BMC Microbiology.
[29] K. Brandenburg,et al. Biophysical Characterization of Lipopolysaccharide and Lipid A Inactivation by Lactoferrin , 2001, Biological chemistry.
[30] K. K. Lai. Enterobacter sakazakii Infections among Neonates, Infants, Children, and Adults: Case Reports and a Review of the Literature , 2001, Medicine.
[31] N. Sharon,et al. Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases , 2000, Glycoconjugate Journal.
[32] Andrea Baroni,et al. Lactoferrin Levels in Term and Preterm Milk , 2000, Journal of the American College of Nutrition.
[33] H. Isoda,et al. Inhibitory Effects of Bovine Lactoferrin on the Adherence of Enterotoxigenic Escherichia coli to Host Cells , 2000, Bioscience, biotechnology, and biochemistry.
[34] B. Finlay,et al. Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells , 1999, Cellular and Molecular Life Sciences CMLS.
[35] B. Finlay,et al. Enteropathogenic E. coli, Salmonella, and Shigella: masters of host cell cytoskeletal exploitation. , 1999, Emerging infectious diseases.
[36] E. Baker,et al. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[37] B. Appelmelk,et al. Lactoferrin is a lipid A-binding protein , 1994, Infection and immunity.
[38] K. Yamauchi,et al. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.
[39] R. Arnold,et al. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin , 1988, Infection and immunity.
[40] P. Visca,et al. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. , 1988, Microbiologica.
[41] R. Arnold,et al. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms , 1980, Infection and immunity.
[42] H. Rogers,et al. Iron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants , 1972, Proceedings of the Royal Society of Medicine.
[43] R. Hutkins,et al. Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host. , 2009, Advances in food and nutrition research.
[44] R. Hancock,et al. Antimicrobial properties of lactoferrin. , 2009, Biochimie.
[45] A. Dugdale,et al. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. , 2009, Journal of medical microbiology.
[46] T. Ochoa,et al. Effect of lactoferrin on enteric pathogens. , 2009, Biochimie.
[47] D. Legrand,et al. Lactoferrin structure and functions. , 2008, Advances in experimental medicine and biology.
[48] T. Ochoa,et al. Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC). , 2004, Advances in experimental medicine and biology.
[49] T. Ochoa,et al. Human lactoferrin impairs virulence of Shigella flexneri. , 2003, The Journal of infectious diseases.
[50] I. Ofek,et al. Bacterial adhesion to animal cells and tissues , 2003 .
[51] O. Conneely,et al. Lactoferrin and host defense. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[52] J. Brock. The physiology of lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[53] D. Newburg,et al. Protective role of human lactoferrin against invasion of Shigella flexneri M90T. , 2001 .